GlassScriptPhysician profile
Srinath T Gowda
NPI 1487768149
$6,283.90
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,595 · 2021: $237 · 2022: $1,596 · 2023: $1,320 · 2024: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,544 · Travel and Lodging: $1,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,543.96 |
| Travel and Lodging | $1,311.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,463.11 | 2022-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Medtronic Vascular, INC. | $1,344.30 | 2019 | |
| Inari Medical, INC. | $1,215.04 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $827.32 | 2021-2024 | Harmony |
| W. L. Gore & Associates, INC. | $140.00 | 2019 | |
| Penumbra, INC. | $134.37 | 2021 | |
| Abbott Laboratories | $111.13 | 2019 | |
| Terumo Medical Corporation | $48.63 | 2024 | Azur Cx Detachable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srinath Gowda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.